Invention Grant
- Patent Title: Bupropion as a modulator of drug activity
-
Application No.: US17468149Application Date: 2021-09-07
-
Publication No.: US11364233B2Publication Date: 2022-06-21
- Inventor: Herriot Tabuteau
- Applicant: ANTECIP BIOVENTURES II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: Maschoff Brennan
- Agent Brent A. Johnson; Yuefen Zhou
- Main IPC: A61K31/439
- IPC: A61K31/439 ; A61K31/165 ; A61K31/485 ; A61K31/135 ; A61K31/137 ; A61K31/15 ; A61K31/343 ; A61K31/381 ; A61K9/00
Abstract:
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.
Public/Granted literature
- US20210401828A1 BUPROPION AS A MODULATOR OF DRUG ACTIVITY Public/Granted day:2021-12-30
Information query
IPC分类:
